Eledon Pharmaceuticals, Inc.
DE ˙ DB ˙ US28617K1016
€ 2,92 ↓ -0.04 (-1.35%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:2TK / Eledon Pharmaceuticals, Inc.
InstitutionState Street Corp
Latest Disclosed Ownership1,154,671 shares
Latest Disclosed Value $ 3,556,387
State Street Corp reports 49.20% increase in ownership of 2TK / Eledon Pharmaceuticals, Inc.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 1,154,671 shares of Eledon Pharmaceuticals, Inc. (DE:2TK) valued at $2,655,743 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 773,885 shares of Eledon Pharmaceuticals, Inc.. This represents a change in shares of 49.20% during the quarter. The current value of the position is $3,371,639 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 1,154,671 380,786 49.20 3,556 204.45 0.0001
2026-02-13 2025-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 773,885 118,409 18.06 1,169 -31.17 0.0000
2025-11-14 2025-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 655,476 50,136 8.28 1,698 3.48 0.0001
2025-08-14 2025-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 605,340 392,239 184.06 1,640 127.15 0.0001
2025-05-15 2025-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 213,101 26,100 13.96 722 -6.23 0.0000
2025-02-14 2024-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 187,001 25,509 15.80 770 91.54 0.0000
2024-11-14 2024-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 161,492 0 0.00 402 -5.63 0.0000
2024-08-14 2024-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 161,492 116,800 261.34 426 363.04 0.0000
2024-05-15 2024-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 44,692 0 0.00 92 15.00 0.0000
2024-02-14 2023-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 44,692 0 0.00 80 31.15 0.0000
2023-11-14 2023-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 44,692 0 0.00 61 0.00 0.0000
2023-08-14 2023-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 44,692 0 0.00 61 -41.90 0.0000
2023-05-15 2023-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 44,692 0 0.00 105 1.94 0.0000
2023-05-15 2022-12-31 13F/A-99 ELEDON PHARMACEUTICALS COM 28617K101 44,692 0 0.00 104 -16.26 0.0000
2023-05-15 2022-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 44,692 0 104 0.0000
2022-11-15 2022-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 44,692 0 0.00 123 12.84 0.0000
2022-08-15 2022-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 44,692 0 0.00 109 -38.07 0.0000
2022-05-16 2022-03-31 13F ELEDON PHARMACEUTICALS COM 28617K101 44,692 4,257 10.53 176 -1.12 0.0000
2022-02-14 2021-12-31 13F ELEDON PHARMACEUTICALS COM 28617K101 40,435 0 0.00 178 -28.80 0.0000
2021-11-15 2021-09-30 13F ELEDON PHARMACEUTICALS COM 28617K101 40,435 7,500 22.77 250 -4.21 0.0000
2021-08-16 2021-06-30 13F ELEDON PHARMACEUTICALS COM 28617K101 32,935 32,935 261 0.0000
2017-08-14 2017-06-30 13F TOKAI PHARMACEUTICALS Common equity shares 88907J107 0 -137,129 -100.00 0 -100.00
2017-05-15 2017-03-31 13F TOKAI PHARMACEUTICALS Common equity shares 88907J107 137,129 -1,200 -0.87 115 -15.44 0.0000
2017-02-09 2016-12-31 13F TOKAI PHARMACEUTICALS Common equity shares 88907J107 138,329 57,972 72.14 136 11.48 0.0000
2017-01-13 2016-09-30 13F/A-1 TOKAI PHARMACEUTICALS Common equity shares 88907J107 80,357 761 0.96 122 -72.21 0.0000
2016-11-14 2016-09-30 13F TOKAI PHARMACEUTICALS Common equity shares 88907J107 80,357 122
2016-08-12 2016-06-30 13F TOKAI PHARMACEUTICALS Common equity shares 88907J107 79,596 -7,171 -8.26 439 -9.86 0.0000
2016-05-20 2016-03-31 13F/A-1 TOKAI PHARMACEUTICALS Common equity shares 88907J107 86,767 5,854 7.23 487 -31.02 0.0001
2016-05-12 2016-03-31 13F TOKAI PHARMACEUTICALS Common equity shares 88907J107 86,767 487
2016-02-16 2015-12-31 13F TOKAI PHARMACEUTICALS Common equity shares 88907J107 80,913 9,416 13.17 706 -4.47 0.0001
2015-11-16 2015-09-30 13F TOKAI PHARMACEUTICALS Common equity shares 88907J107 71,497 15,194 26.99 739 -1.60 0.0001
2015-08-13 2015-06-30 13F TOKAI PHARMACEUTICALS Common equity shares 88907J107 56,303 10,954 24.15 751 46.68 0.0001
2015-05-15 2015-03-31 13F TOKAI PHARMACEUTICALS Common equity shares 88907J107 45,349 17,020 60.08 512 22.78 0.0001
2015-02-11 2014-12-31 13F TOKAI PHARMACEUTICALS Common equity shares 88907J107 28,329 28,329 417 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.